Prime Medicine, Inc. (PRME) Insider Trading Disclosures
Prime Medicine, Inc. (PRME) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PRME
CIK: 1894562
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerKenneth Richardson
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001628280-26-053883 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001628280-26-053878 | View SEC Doc Filr Page |
| 8-K | 2026-07-08 | 2026-07-06 | 8-K | 0001628280-26-047590 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | FORM 4 | 0001628280-26-041579 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | FORM 4 | 0001628280-26-041575 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | FORM 4 | 0001628280-26-041572 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | FORM 4 | 0001628280-26-041569 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | FORM 4 | 0001628280-26-041566 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | FORM 4 | 0001628280-26-041560 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | FORM 4 | 0001628280-26-041553 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-05 | 8-K | 0001628280-26-041543 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001628280-26-031726 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001628280-26-031719 | View SEC Doc Filr Page |
| ARS | 2026-04-23 | 2025-12-31 | ARS | 0001628280-26-026704 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-23 | — | DEFA14A | 0001628280-26-026701 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-23 | 2025-12-31 | DEF 14A | 0001628280-26-026697 | View SEC Doc Filr Page |
| 4 | 2026-04-17 | 2026-04-16 | FORM 4 | 0001470831-26-000388 | View SEC Doc Filr Page |
| 3 | 2026-04-17 | 2026-04-16 | FORM 3 | 0001470831-26-000386 | View SEC Doc Filr Page |
| 8-K | 2026-04-16 | 2026-04-07 | 8-K | 0001628280-26-025372 | View SEC Doc Filr Page |
| EFFECT | 2026-03-04 | — | EFFECT Filing | 9999999995-26-000723 | View SEC Doc Filr Page |
| S-8 | 2026-03-03 | — | S-8 | 0001628280-26-013575 | View SEC Doc Filr Page |
| POS AM | 2026-03-03 | — | POS AM | 0001894562-26-000009 | View SEC Doc Filr Page |
| 10-K | 2026-03-03 | 2025-12-31 | 10-K | 0001628280-26-013569 | View SEC Doc Filr Page |
| POSASR | 2026-03-03 | — | POSASR | 0001894562-26-000007 | View SEC Doc Filr Page |
| 8-K | 2026-03-03 | 2026-03-03 | 8-K | 0001628280-26-013565 | View SEC Doc Filr Page |